FierceBiotech ٢١ يناير ٢٠٢٦ Nkarta’s CEO wore head-to-toe pink at JPM. Here’s why it matters more than ever
FierceBiotech ٢٠ يناير ٢٠٢٦ Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
FierceBiotech ٢٠ يناير ٢٠٢٦ Boundless finally gives up on combo treatment of 2 unimpressive cancer drugs
FierceBiotech ٢٠ يناير ٢٠٢٦ Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis
FierceBiotech ٢٠ يناير ٢٠٢٦ Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark
FierceBiotech ٢٠ يناير ٢٠٢٦ Pfizer pens $530M deal to use Novavax's vaccine adjuvant tech on 2 programs
FierceBiotech ٢٠ يناير ٢٠٢٦ GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair
FierceBiotech ٢٠ يناير ٢٠٢٦ ARPA-H director eyes future beyond vaccines, ‘winning the biotech race’ against China
FierceBiotech ١٩ يناير ٢٠٢٦ FDA Grants RMAT Designation to iRegene’s NouvNeu001, Cementing its Lead as the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
FierceBiotech ١٩ يناير ٢٠٢٦ AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta
FierceBiotech ١٩ يناير ٢٠٢٦ Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions
FierceBiotech ١٦ يناير ٢٠٢٦ Vedanta ‘significantly’ reduces headcount to fund lead bacteria cocktail program
FierceBiotech ١٦ يناير ٢٠٢٦ ImmunityBio touts 15-month complete response in off-the-shelf CAR-NK trial